T1	HMM 26 32	effect
T2	HMM 151 175	clinical curative effect
T3	HMM 366 380	nerve function
T4	HMM 599 631	treatment, nerve function defect
T5	HMM 731 756	Treatment effective rates
T6	HMM 852 919	reduce the GBS patients' blood immunoglobulin IgG, IgA, IgM, C3 and
T7	HMM 992 998	group.
T8	HMM 999 1006	Fib and
